Discovery and structure–activity relationship of coumarin derivatives as TNF-α inhibitors
Authors:
- 17 May 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (10) , 2411-2415
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Novel chromene derivatives as TNF-α inhibitorsBioorganic & Medicinal Chemistry Letters, 2003
- Anti-TNF-α therapies: the next generationNature Reviews Drug Discovery, 2003
- The TNF and TNF Receptor SuperfamiliesCell, 2001
- Inhibitors of NF-κB and AP-1 Gene Expression: SAR Studies on the Pyrimidine Portion of 2-Chloro-4-trifluoromethylpyrimidine-5-[N-(3‘,5‘-bis(trifluoromethyl)phenyl)carboxamide]Journal of Medicinal Chemistry, 2000
- Anti-TNF agents in Crohn’s diseaseExpert Opinion on Investigational Drugs, 2000
- Clinical and pharmacological experience with etanerceptExpert Opinion on Investigational Drugs, 1999
- The therapeutic potential of small molecule TACE inhibitorsExpert Opinion on Investigational Drugs, 1999
- TNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling ComplexImmunity, 1996
- The effect of cloricromene, a coumarine derivative, on leukocyte accumulation, myocardial necrosis and TNF-α production in myocardial ischaemia-reperfusion injuryLife Sciences, 1993
- Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.Journal of Experimental Medicine, 1991